Logo

Trovagene

Trovagene Enters Deal With Novogene for NextCollect in China

Novogene will validate Trovagene's proprietary urine collection and nucleic acid preservation device, NextCollect, and develop tests for the Chinese market.

Trovagene Inks Cancer Biomarker Deal With AstraZeneca

AstraZeneca will use Trovagene's Trovera EGFR urine liquid biopsy test in an open-label prospective biomarker study.

Trovagene Q4 Revenues Down, Company Restructuring to Expand Into Therapeutics

The firm announced a 14 percent drop year-over-year in fourth quarter revenues and plans to reduce personnel and other costs to support development of a precision drug it has licensed.

Trovagene Signs Deals to Distribute Liquid Biopsy Tests in Europe, Middle East

The distributors will promote Trovagene's clinical test services, and will also gain access to the research-use kits the firm is co-developing with Boreal Genomics.

Trovagene Reorganizes After Boreal Deal, Cuts 20 Jobs

The company believes that the reduction in staff and marketing costs for its testing services will reduce its annual pre-tax expenses by about $4 million.

Nov 30, 2016

Trovagene, Boreal Genomics to Co-Develop Kits for ctDNA Analysis

Nov 9, 2016

Trovagene Q3 Revenues Climb 56 Percent

Oct 4, 2016

Pancreatic Cancer Action Network Unveils Precision Medicine Clinical Trial

Aug 17, 2016

BCBS Illinois to Cover Trovagene Liquid Biopsy Tests

Aug 4, 2016

Trovagene Q2 Revenues Grow But Miss Estimates

Jul 29, 2016

Trovagene's Dual-Sample Liquid Biopsy Performs Well in First Peer-Reviewed Study
Premium

Jul 12, 2016

Trovagene, USC Collaborate on Deployment of Urine-Based Liquid Biopsy Test

Jul 6, 2016

Trovagene, University of Michigan to Collaborate on Pancreatic Cancer Monitoring, Early Detection

May 10, 2016

Trovagene Q1 Revenues Fall 6 Percent as Net Loss Swells

Mar 29, 2016

Trovagene Terminates CEO Schuh and CFO Zaniboni for Breach of Duty

Mar 10, 2016

Trovagene Q4 Revenues up 41 Percent as Net Loss Widens

Feb 1, 2016

Trovagene Inks Deal to Provide Liquid Biopsies Through PPO FedMed

Jan 21, 2016

Trovagene to Offer Liquid Biopsy Through America's Choice Provider Network

Nov 9, 2015

Trovagene Reports Flat Q3 Revenues; Halves Net Loss

Sep 16, 2015

Cantor Fitzgerald Starts Coverage of Trovagene With Buy Rating

Sep 10, 2015

Trovagene Forms European Institute Headed by U Torino Researcher Alberto Bardelli

Aug 14, 2015

Leerink Initiates Coverage of Trovagene with Outperform Rating

Aug 10, 2015

Trovagene's Q2 Net Loss Swells 10-Fold on Increased Operating Expenses

Jul 22, 2015

Trovagene Raises $40M in Public Offering of Shares

Jul 17, 2015

Trovagene Prices $35M Stock Offering

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.